Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,625.53 -58.45 -2.18%
FTSE 100 6,224.03 -124.79 -1.97%
DAX 8,011.24 -185.84 -2.27%
Ticker Volume Price Price Delta
Nikkei 13,014.60 -230.64 -1.74%
Hang Seng 20,382.90 -604.02 -2.88%
S&P/ASX 200 4,758.39 -102.99 -2.12%
  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Benitec Biopharma Ltd

+ Add to Watchlist

BNIKF:US

0.0190 USD 0.00000.00%

As of 20:10:00 ET on 05/10/2013.

Company Profile for Benitec Biopharma Ltd (BNIKF)

Benitec Biopharma Ltd. is a medical technology research and development Company. The Company's research focuses on the gene-technology field to find ways to fight cancer causing cells. Benitec's research encompasses a gene silencing technology in mammalian cells.

Contact Information

Benitec Biopharma Ltd

Level 16
356 Collins Street
Melbourne, VIC 3000
Australia
Phone: 61-2-9555-6986
Fax: 61-3-8678-1342

Key Executives for Benitec Biopharma Ltd (BNIKF)

Peter FrenchChief Executive OfficerMichael W GrahamChief Scientific Officer
Gregory West "Greg"Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil